← Research library

Experience using Phenotropil in combined treatment of multiple sclerosis

Observational study · 2010

What was studied
39 patients with relapsing or secondary-progressive multiple sclerosis
Main finding
The report examines asthenia, mood and quality-of-life measures during adjunctive treatment. Most participants also received disease-modifying therapy.

Study data at a glance

Participants or experimental model
39 patients with relapsing or secondary-progressive multiple sclerosis
Reported results
The report examines asthenia, mood and quality-of-life measures during adjunctive treatment. Most participants also received disease-modifying therapy.
Study limitations and source details

Study limitations

  • Uncontrolled adjunctive design; treatment contributions cannot be separated.
  • The host labels the reprint as Atmosfera, No. 4, 2010; earlier reprints circulate and edition matching remains open.

Source details

Original study text in a medical-portal reprint checked; publication edition not independently matched.

Sources checked

Citation

Uncontrolled human reportRussian-language source

D. V. Sazonov, O. V. Ryabukhina, E. V. Bulatova, N. A. Malkova, A. V. Babenko. Experience using Phenotropil in combined treatment of multiple sclerosis Atmosfera. Nervnye bolezni. No. 4, 2010, as labeled by host

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards